Agency for Toxic Substances and Disease Registry
Radiation Exposure from Iodine 131
References and Suggested Reading List (continued)
International Atomic Energy Agency and World Health Organization. 1998. Planning the medical response to radiological accidents. IAEA Safety Report Series No. 4. Vienna: International Atomic Energy Agency. p. 15-21.
International Commission on Radiological Protection. 1991. Recommendations of the ICRP. Oxford (UK): Pergamon Press. ICRP Publication 60. Ann ICRP 21(1-3).
International Commission on Radiological Protection. 1995. Age-dependent doses to members of the public from intake of radionuclides: part 2. Ingestion dose coefficients. ICRP Publication 67. Ann ICRP 23(3-4).
Ivanov VK, Gorsky AI, Tsyb AF, Maksyutov MA, Rastopchin EM. 1999. Dynamics of thyroid cancer incidence in Russia following the Chernobyl nuclear accident. J Radiol Prot 19(4):305-18.
Jacob P, Kenigsberg Y, Zvonova I, Goulko G, Buglova E, Heidenreich WF, et al. 1999. Childhood exposure due to the Chernobyl accident and thyroid cancer risk in contaminated areas of Belarus and Russia. Br J Cancer 80(9):1461-9.
Jacob P, Kenigsberg Y, Goulko G, Buglova E, Gering F, Golovneva A, et al. 2000. Thyroid cancer risk in Belarus after the Chernobyl accident: comparison with external exposures. Radiat Environ Biophys 39(1):25-31.
Jankowski J. 1996. The consequences of the Chernobyl accident one decade after the disaster. Int J Occup Med Environ Health 9(4):365-74.
Kenigsberg J, Buglova E. 1996. Assessment of the thyroid protection efficiency for Belarusian children after the Chernobyl accident. Proceedings of the 1996 International Congress of Radiation Protection (IRPA 9). Paris: Fontenay-aux-Roses. Vol. 3. p. 245-6.
Kerber RA, Till JE, Simon SL, Lyon JL, Thomas DC, Preston-Martin S, et al. 1993. A cohort study of thyroid disease in relation to fallout from nuclear weapons testing. JAMA 270(17):2076-82.
Kotz D. 2000. Hanford: study leaves questions about increased thyroid cancer rates unanswered. J Nucl Med 41(4):17N-18N, 21N, 25N.
Larsen PR, Davies TF, Hay ID. 1998. The thyroid gland. In: Endocrinology. 9th edition. Philadelphia: Williams. p. 389-515.
Lin JD, Wang HS, Weng HF, Kao PF. 1998. Outcome of pregnancy after radioactive iodine treatment for well differentiated thyroid carcinomas.
J Endocrinol Invest 21:662-7.
Lloyd RD, Tripp DA, Kerber RA. 1996. Limits of fetal thyroid risk from radioiodine exposure. Health Phys 70(4):559-62.
Lombard J, Coulon R, Despres A. 1988. An ALARA approach to the radiological control of foodstuffs following an accidental release. Risk Anal 8(2):283-90.
Maxon HR, Saenger EL. 1996. Biologic effects of radioiodines on the human thyroid gland. In: Braverman LE, Utiger RD. Werner and Ingbar's the thyroid. 7th edition. Philadelphia: Lippincott-Raven. p. 332-50.
Nagataki S, Shibata Y, Inoue S, Yokoyama N, Izumi M, Shimaoka K. 1994. Thyroid diseases among atomic bomb survivors in Nagasaki. JAMA 272(5):364-70.
Naik KS, Bury RF. 1998. Imaging the thyroid. Clin Radiol 53(9):630-9.
National Cancer Institute. 1997. Estimated exposures and thyroid doses received by the American people from iodine 131 in fallout following Nevada atmospheric nuclear bomb tests. A report from the National Cancer Institute. Bethesda: US Department of Health and Human Services.
Newcomb MD. 1986. Nuclear attitudes and reactions: associations with depression, drug use, and quality of life. J Pers Soc Psychol 50(5):906-20.
Niedenthal J. 1997. A history of the people of Bikini following nuclear weapons testing in the Marshall Islands: with recollections and views of elders of Bikini Atoll. Health Phys 73(1):28-36.
Nuclear Regulatory Commission. 2001. Standards for protection against radiation (10CFR20-35). Washington, DC: US Nuclear Regulatory Commission.
Oertel YC. 1996. Fine-needle aspiration and the diagnosis of thyroid cancer. Endocrinol Metab Clin North Am 25(1):69-91.
O'Hare NJ, Gilligan P, Murphy D, Malone JF. 1997. Estimation of foetal brain dose from I-131 in the foetal thyroid. Phys Med Biol 42(9):1717-26.
Pacini F, Vorontsova T, Molinaro E, Shavrova E, Agate L, Kuchinskaya E, et al. 1999. Thyroid consequences of the Chernobyl nuclear accident. Acta Pediatr Suppl 88(433):23-7.
Petrone LR. 1996. A primary care approach to the adult patient with nodular thyroid disease. Arch Fam Med 5(2):92-100.
Prisyazhniuk A, Gritschenko V, Zakordonets V, Fouzik N, Slipeniuk Y, Ryzhak I. 1995. The time trends of cancer incidence in the most contaminated regions of the Ukraine before and after the Chernobyl accident. Radiat Environ Biophys 34:3-6.
Rallison ML, Lotz TM, Bishop M, Divine W, Haywood K, Lyon JL, et al. 1990. Cohort study of thyroid disease near the Nevada Test Site: a preliminary report. Health Phys 59(5):739-46.
Ramsdell JV Jr, Simonen CA, Burk KW, Stage SA. 1996. Atmospheric dispersion and deposition of 131I released from the Hanford Site. Health Phys 71(4):568-77.
Risk Assessment Corporation. 2001. Savannah River Site Environmental Dose Reconstruction Project. Final Report. URL: http://www.cdc.gov/nceh/radiation/savannah/Cover.pdf. 
Robbins J. 1997. Lessons from Chernobyl: the event, the aftermath fallout: radioactive, political, social. Thyroid 7(2):189-192.
Robkin MA, Shleien B. 1995. Estimated maximum thyroid doses from 129I releases from the Hanford site for the years 1944-1995. Health Phys 69(6):917-22.
Sandman P. 1993. Responding to community outrage: strategies for effective risk communication. Fairfax, VA: American Industrial Hygiene Association.
Schlumberger M, De Vathaire F, Ceccarelli C, Delisle MJ, Francese C, Couette JE, et al. 1996. Exposure to radioactive iodine-131 for scintigraphy or therapy does not preclude pregnancy in thyroid cancer patients. J Nucl Med 37(4):606-12.
Schottenfeld RS. 1992. Psychologic sequelae of chemical and hazardous materials exposures. In: Sullivan JB, Kriger GR, editors. Hazardous materials toxicology. Clinical principles of environmental health. Baltimore: Williams & Wilkins. p. 463-70.
Shipler DB, Napier BA, Farris WT, Freshley MD. 1996. Hanford Environmental Dose Reconstruction Project-an overview. Health Phys 71(4):532-44.
Sipes IG, McQueen CA, Gandolfi AJ. 1997. Comprehensive toxicology. Vol 10. Oxford, UK: Elsevier Science. p. 692-9.
Slaback LA, Birky B, Shleien B. 1997. Handbook of health physics and radiological health. New York: Williams and Wilkins.
Slovic P. 1987. Perception of risk. Science 236(4799):280-5.
Smith MB, Xue H, Takahashi H, Cangir A, Andrassy RJ. 1994. Iodine 131 thyroid ablation in female children and adolescents: long-term risk of infertility and birth defects. Ann Surg Oncol 1(2):128-31.
Stern TA, Herman JB. 2000. Massachusetts General Hospital psychiatry: update and board preparation. New York: USA: McGraw-Hill Companies, Inc.
Takahashi T, Trott KR, Fujimori K, Simon SL, Ohtomo H, Nakashima N, et al. 1997. An investigation into the prevalence of thyroid disease on Kwajalein Atoll, Marshall Islands. Health Phys 73(1):199-213.
Tezelman S, Grossman RF, Siperstein AE, Clark OH. 1994. Radioiodine-associated thyroid cancers. World J Surg 18(4):522-8.
Tsunoda T, Mochinaga N, Eto T, Maeda H. 1991. Hyperparathyroidism following the atomic bombing in Nagasaki. Jpn J Surg 21(5):508-11.
United Nations Scientific Committee on the Effects of Atomic Energy. 2000a. Sources and effects of ionizing radiation. Vienna: United Nations Scientific Committee on the Effects of Atomic Energy. Vol. I: sources.
United Nations Scientific Committee on the Effects of Atomic Energy. 2000b. Sources and effects of ionizing radiation. Vienna: United Nations Scientific Committee on the Effects of Atomic Energy. Vol. II: effects.
US Nuclear Regulatory Commission. 1994. Release of patients administered radioactive materials. Regulatory guide 8.39. Washington, DC: US Nuclear Regulatory Commission.
Verellen D, Vanhavere F. 1999. Risk assessment of radiation-induced malignancies based on whole-body equivalent dose estimates for IMRT treatment in the head and neck region. Radiother Oncol 53(3):199-203.
Voelz GL. 1994. Ionizing radiation. In: Zenz C, Dickerson OB, Horvath EP, editors. Occupational medicine. 3rd edition. St. Louis, MO: Mosby. p. 393-425.
Voelz GL. 1995. Occupational injuries caused by radiation exposure. In: Herington TN, Morse LH, editors. Occupational injuries. Evaluation, management, and prevention. St. Louis, MO: Mosby. p. 447-68.
Vyner HM. 1988. The psychological dimensions of health care for patients exposed to radiation and the other invisible contaminants. Soc Sci Med 27(10):1097-103.
Walsh RM, Watkinson JC, Franklyn J. 1999. The management of the solitary thyroid nodule: a review. Clin Otolaryngol 24(5):388-97.
Walters RH, Richmond MC, Gilmore BG. 1996. Reconstruction of radioactive contamination in the Columbia River. Health Phys 71(4):556-67.
Whicker FW, Pinder JE. 2002. Food chains and biogeochemical pathways. Health Phys 82(5):680-9.
[WHO] World Health Organization. 1999. Guidelines for iodine prophylaxis following nuclear accidents. Update 1999. Geneva: World Health Organization. WHO/SDE/PHE/99.6. Available from URL: http://www.who.int/entity/ionizing_radiation/pub_meet/en/Iodine_Prophylaxis_guide.pdf.
Zanzonico PB. 2000. Age-dependent thyroid absorbed doses for radiobiologically significant radioisotopes of iodine. Health Phys 78(1):60-7.
Zeighami EA, Morris MD. 1986. Thyroid cancer risk in the population around the Nevada Test Site. Health Phys 50(1):19-32.
Zuniga-Gonzalez S. 2000. Thyroiditis induced by radioactive iodine (I-131). Report of a case and review of the literature. Gac Med Mex 136(1):65-9.
Previous Section Next Section
|
